↓ Skip to main content

Changing the role of pCR in breast cancer treatment - an unjustifiable interpretation of a good prognostic factor as a “factor for a good prognosis“

Overview of attention for article published in Frontiers in oncology, July 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Changing the role of pCR in breast cancer treatment - an unjustifiable interpretation of a good prognostic factor as a “factor for a good prognosis“
Published in
Frontiers in oncology, July 2023
DOI 10.3389/fonc.2023.1207948
Pubmed ID
Authors

Nebojsa Ivanovic, Dragana Bjelica, Barbara Loboda, Masan Bogdanovski, Natasa Colakovic, Simona Petricevic, Milan Gojgic, Ognjen Zecic, Katarina Zecic, Darko Zdravkovic

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 25%
Student > Bachelor 1 25%
Unknown 2 50%
Readers by discipline Count As %
Medicine and Dentistry 1 25%
Neuroscience 1 25%
Unknown 2 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2023.
All research outputs
#21,631,663
of 26,587,829 outputs
Outputs from Frontiers in oncology
#11,959
of 23,506 outputs
Outputs of similar age
#277,275
of 375,570 outputs
Outputs of similar age from Frontiers in oncology
#388
of 1,057 outputs
Altmetric has tracked 26,587,829 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,506 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 375,570 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,057 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.